Can-Fite BioPharma
Can-Fite BioPharma develops small molecule drugs targeting oncological, inflammatory, and metabolic diseases.
6-KNov 12Latest SEC filing
Nov 12Latest story
November 2026
October 2026
September 2026
August 2026
July 2026
Can-Fite BioPharma develops small molecule drugs targeting oncological, inflammatory, and metabolic diseases.
November 2026
October 2026
September 2026
August 2026
July 2026